Imputus Pharamaceuticals Private Limited
About Imputus Pharamaceuticals Private Limited
Data last updated:
Imputus Pharamaceuticals Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 05 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U74999UR2017PTC007937. Its GSTIN is 05AAECI5537P1Z5 (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shailesh Maikhuri and Yogambar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jagrati Complex Ring Road, Dehradun, Uttarakhand, India – 248001.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.21 Lakh, a growth of 27% compared to the previous year. For the same year it recorded a net loss of ₹5,434 (net margin -0.9%) and EBITDA of -₹5,434 (EBITDA margin -0.9%). Revenue has grown at a compounded annual rate (CAGR) of 89% over three years and 65% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Imputus Pharamaceuticals Private Limited's registered office is in Dehradun, Uttarakhand. Its e-mail address is in the company report.
- Email
- Registered AddressJagrati Complex Ring Road, Dehradun, Uttarakhand, India – 248001
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Imputus Pharamaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Imputus Pharamaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Imputus Pharamaceuticals Private Limited, buy the company report.
Financials of Imputus Pharamaceuticals Private Limited
FY 2025 filings availableImputus Pharamaceuticals Private Limited reported revenue of ₹6.21 Lakh (up 27% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 65% over five years, including 27% growth in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5,434 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5,434 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.9% | ||||
| Net Profit Margin | -0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Imputus Pharamaceuticals Private Limited, buy the company report.
Board of directors of Imputus Pharamaceuticals Private Limited
Imputus Pharamaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailesh Maikhuri | Director | 05 Jul 2017 | 9 Years 4 Months | Current |
| Yogambar Singh | Director | 05 Jul 2017 | 9 Years 4 Months | Current |
Peer comparison
Imputus Pharamaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunflo Pharmaceuticals Private Limited | ₹6.24 Lakh (FY 2018) | -53.0% | Kalyan, Maharashtra, India | |||
| Texkare Sciences Private Limited | ₹6.24 Lakh (FY 2017) | 247.0% | Thane, Maharashtra, India | |||
| Udvell Pharmaceuticals Private Limited | ₹6.22 Lakh (FY 2022) | 210.0% | Tehri Garwal, Uttarakhand, India | |||
| KNBC Pharma Solutions Private Limited | ₹6.21 Lakh (FY 2018) | -81.0% | Hyderabad, Telangana, India | |||
| Velid Chemicals Private Limited | ₹6.21 Lakh (FY 2025) | Secunderabad, Telangana, India | ||||
| Imputus Pharamaceuticals Private Limitedthis company | ₹6.21 Lakh (FY 2025) | -₹5,434 | -0.9% | 27.0% | Dehradun, Uttarakhand, India | |
| Holista Ingredients India Private Limited | ₹6.21 Lakh (FY 2022) | 61026.0% | Mumbai, Maharashtra, India | |||
| Rockvet Pharmaceuticals Private Limited | ₹6.2 Lakh (FY 2024) | 146.0% | Faridabad, Haryana, India | |||
| Bouvya Hardware and Chemicals Private Limited | ₹6.2 Lakh (FY 2020) | 21.0% | Nalagonda, Telangana, India | |||
| Laurexbio Labs Private Limited | ₹6.19 Lakh (FY 2022) | Bangalore, Karnataka, India | ||||
| B. M. Pharmachem (India) Private Limited | ₹6.19 Lakh (FY 2025) | -99.0% | Ankleshwar, Gujarat, India |
To see the full peer comparison of Imputus Pharamaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Imputus Pharamaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Imputus Pharamaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Imputus Pharamaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAECI5537P1Z5 | Uttarakhand | Active | 14 Oct 2017 |
To see the full GST registrations and return filing status of Imputus Pharamaceuticals Private Limited, buy the company report.
Recent activity
Imputus Pharamaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Shailesh Maikhuri was appointed as Director on 05 Jul 2017.
Frequently asked questions
Imputus Pharamaceuticals is an active private limited company based in Dehradun, Uttarakhand, India. The company works in other services, within the business services industry. It was incorporated on 05 July 2017 (9+ years old) and is registered under CIN U74999UR2017PTC007937.
Imputus Pharamaceuticals has 2 current directors:
- Shailesh Maikhuri - Director
- Yogambar Singh - Director
The latest financial statements of Imputus Pharamaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Imputus Pharamaceuticals is 05AAECI5537P1Z5, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Imputus Pharamaceuticals is U74999UR2017PTC007937. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Imputus Pharamaceuticals was incorporated on 05 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Imputus Pharamaceuticals by revenue are Sunflo Pharmaceuticals Private Limited, Texkare Sciences Private Limited, Udvell Pharmaceuticals Private Limited, KNBC Pharma Solutions Private Limited, Velid Chemicals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shailesh Maikhuri was appointed as Director on 05 Jul 2017. Yogambar Singh was appointed as Director on 05 Jul 2017.
The registered office of Imputus Pharamaceuticals is at Jagrati Complex Ring Road, Dehradun, Uttarakhand, India – 248001.
Imputus Pharamaceuticals operates in the business services industry, in the other services segment.
The compliance status of Imputus Pharamaceuticals is compliant as of 20 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
